Chief of Staff, Abramson Cancer Center
Director, Penn Cardiology Fellow's Practice
Clinical Professor of Medicine

E-Mail

Hospital of The University of Pennsylvania
Abramson Cancer Center
1600 Penn Tower
3400 Spruce Street
Philadelphia, PA 19104

Appointments

Contact: Connie Turner (215) 615-3031
Assistant: Michelle Ward (215) 662-3917

Clinical Specialty:

• Cardiovascular Medicine
• Oncologic Cardiology (Care of the cardiac complications of cancer, its treatment and long term survivorship)

Practice Location:

• Hospital of The University of Pennsylvania, Penn Tower
• Hospital of The University of Pennsylvania, Ground Rhoads Pavilion

Education:

• MD: Hahnemann University School of Medicine
• Residency: Hahnemann University Hospital
• Fellowship: Hahnemann University Hospital

Research Interest:

• Cardiac problems associated with cancer
• Long term cardiac effects in long term cancer survivors

Selected Publications:

1. Packer M, Carver J, Rodeheffer RJ, et al. Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure. New England J of Medicine 325:1468, 1991.
2. Carver J, Harmon Weiss S, Cannon M. The Safety and Efficacy of Continuous Heparin in the Home.  American J. of Managed Care 1: 143, 1995
3. Califf RM, Armstrong PW, Carver JR, et al.  Task Force 5.  Stratification of Patients into High, Medium and Low Risk Subgroups for Purposes of Risk Factor Management.  J. of American Col. Of Cardiology 27:1007, 1996
4. Hahn T, Wingard JR, Anderson KC, Bensinger WI, Berenson GB,   Carver JR, Kyle RA, McCarthy PL.  The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Multiple Myeloma:  An Evidence-based Review. Biology of Blood and Marrow Transplantation 2003;9:4-37.
5. Vogl DT, Glatstein E, Carver JR, et al. Gemcitabin-induced pericardial effusion and tamponade after unblocked cardiac irradiation. Leukemia and Lymphoma 2005;46:1313-1320.
6. Carver JR, Shapiro CE, Ng A, Vaughn DJ. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiopulmonary late effects. in press